High-flow Nasal Oxygen Therapy for Advanced Endoscopy in High-risk Patients.

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

September 12, 2025

Study Completion Date

September 12, 2025

Conditions
Hypoxemia During Surgery
Interventions
DEVICE

HFNO-Treatment

The investigated intervention is the application of HFNO throughout a high-risk upper GI-endoscopy. Concentration of oxygen is 100%. Prior to induction, flow rate is set to 20 l/min and increased to 30 l/min if tolerated by the patient. After induction of anesthesia, flow rate is increased to 60 l/min and maintained throughout the anesthesia.

Trial Locations (1)

02215

Anesthesia, Critical Care and Pain Medicine Department at Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT06610461 - High-flow Nasal Oxygen Therapy for Advanced Endoscopy in High-risk Patients. | Biotech Hunter | Biotech Hunter